194 related articles for article (PubMed ID: 8678521)
1. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
[TBL] [Abstract][Full Text] [Related]
3. [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].
Ohmori H; Ohashi T; Aso Y; Kumamoto Y; Hisazumi H; Shiraiwa Y; Kurita T; Shimazaki J; Ohkawa T; Ogawa H
Hinyokika Kiyo; 1988 Dec; 34(12):2101-10. PubMed ID: 3071123
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
Hamase A; Kawanaka M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
[TBL] [Abstract][Full Text] [Related]
5. [Tag 72: a new tumor-associated antigen identified by a monoclonal antibody].
Piantino P; Fusaro A; Daziano E; Polloni R; Mosso R; Cacace G
Minerva Med; 1990 Nov; 81(11):765-7. PubMed ID: 2255410
[TBL] [Abstract][Full Text] [Related]
6. [Trials of the diagnostic potentials of TPA in tumorous and nontumorous lung pathologies in 303 cases].
Aquilina R; Bergero F; Magri G; Noceti P; Mirabelli S
Minerva Med; 1992; 83(7-8):415-9. PubMed ID: 1522964
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
[TBL] [Abstract][Full Text] [Related]
8. [Immunoradiometric assay of tumor marker CA15-3 and its clinical application].
Chen Z; Fan Z; Yang J
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):125-8. PubMed ID: 10920962
[TBL] [Abstract][Full Text] [Related]
9. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of serum tissue-polypeptide antigen (TPA) levels by EIA employing monoclonal antibody].
Takami H
Gan To Kagaku Ryoho; 1994 May; 21(6):853-8. PubMed ID: 8185344
[TBL] [Abstract][Full Text] [Related]
11. [An immunoradiometric assay of the serum TPA from patients with primary lung cancer and a comparison with the conventional double antibody method].
Suzuki K; Reshad K; Akiyama J; Itoi K; Hirata T; Muro K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):703-11. PubMed ID: 2552212
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A
Anticancer Res; 1996; 16(6B):3793-8. PubMed ID: 9042259
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new monoclonal radioimmunoassay system for carcinoembryonic antigen.
Matsuoka Y; Kuroki M; Okamoto N; Ikeda S; Hara Y; Minamizawa T; Tachibana S; Ogawa H; Tabata N
Jpn J Clin Oncol; 1988 Jun; 18(2):97-103. PubMed ID: 2454336
[TBL] [Abstract][Full Text] [Related]
14. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
15. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
[TBL] [Abstract][Full Text] [Related]
16. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
[TBL] [Abstract][Full Text] [Related]
17. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
19. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
[TBL] [Abstract][Full Text] [Related]
20. [Determination of the cut-off for marker TPA in healthy children].
Magrì G; Giargia L
Minerva Pediatr; 1994 Nov; 46(11):517-9. PubMed ID: 7870010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]